Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 1

Status

Recruiting 12Completed 4Unknown 3Terminated 3Active not recruiting 3Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Breast Neoplasms 9Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Recurrence 5Pancreatic Neoplasms 5Neoplasms 5Stomach Neoplasms 4Solid Tumor 4Melanoma 4Liver Neoplasms 4Advanced Solid Tumors 4Neoplasm Metastasis 3Nasopharyngeal Carcinoma 3Leukemia, Myeloid, Acute 3Biliary Tract Neoplasms 3Advanced Solid Tumor 3Triple Negative Breast Neoplasms 2Thoracic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Multiple Myeloma 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Squamous Cell Lung Cancer 1

Interventions

spartalizumab 3Injections 3camrelizumab 2anlotinib 2Therapeutics 2Cisplatin 2Capecitabine 2toripalimab 1tislelizumab 1pembrolizumab 1fludarabine 1donafenib 1Pemetrexed 1PM 01183 1Leucovorin 1Irinotecan 1Injections, Intravenous 1Gemcitabine 1Fluorouracil 1Cyclophosphamide 1Carboplatin 15'-Nucleotidase 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Advanced Solid Tumor × Injections × Clear all
NCT06008366 2023-09-13

A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1/2 Unknown
281 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06008379 2023-09-13

A Study of 7MW3711 in Subjects With Advanced Solid Tumors

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1/2 Unknown
164 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT05429398 2022-06-23

A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor

Shanghai YingLi Pharmaceutical Co. Ltd.

Phase 1 Unknown
118 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡